Evidence map›Paper›PMID 21844802›Full record

ReviewCurrent opinion in infectious diseases2011

Microsporidiosis: not just in AIDS patients.

Elizabeth S Didier, Louis M Weiss

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 164 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed, 1 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 1 synthesis or guideline pooled it, 327 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Prevalence of Enterocytozoon bieneusi and Encephalitozoon spp. in Swedish patients with suspected gastrointestinal parasite infection: a cross-sectional molecular study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. A New Host-Parasite Association: ALife (Basel, Switzerland) · 2026
    Article
  6. Prevalence and Multi-Locus Genotyping ofAnimals : an open access journal from MDPI · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Microsporidia in Rodents-Animals : an open access journal from MDPI · 2025
    Article
  12. Investigation of Infection ofVeterinary sciences · 2025
    Article
  13. Molecular Detection ofPathogens (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Elizabeth S DidierDivision of Microbiology, Tulane National Primate Research Center, Covington, Louisiana, USA.
Louis M Weiss
Albert Einstein College of Medicine · USTulane University · US

Funding

ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 1985 to 2011
$100.1M
New Opportunistic Infections in AIDS MicrosporidosisR01AI031788 · NIAID · YESHIVA UNIVERSITY · PI WEISS, LOUIS M. · 1992 to 2011
$4.6M
Dendritic Cell Response to MicrosporidiansR01AI071778 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KHAN, IMTIAZ AHMED · 2006 to 2010
$2.6M
Microsporidia: Genetic TechniquesR21AI093315 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI WEISS, LOUIS M. · 2011 to 2012
$457k
NCRR NIH HHS P51 RR000164NCRR NIH HHS RR00164NIAID NIH HHS AI071778NIAID NIH HHS R01 AI031788NIAID NIH HHS R01 AI071778NIAID NIH HHS R21 AI093315
6 · The paper itself

Abstract

purpose of reviewMicrosporidia have emerged as causes of opportunistic infections associated with diarrhea and wasting in AIDS patients. This review describes recent reports of microsporidiosis in HIV-infected individuals and the growing awareness of microsporidiosis in non-HIV-infected populations. RECENT

findingsMicrosporidia were only rarely recognized as causes of disease in humans until the AIDS pandemic. Implementation of combination antiretroviral therapy (cART) to curtail HIV replication and restore immune status drastically reduced the occurrence of opportunistic infections, including those due to microsporidia, in HIV-infected individuals. In developing countries where cART is not always accessible, microsporidiosis continues to be problematic. Improvement of diagnostic methods over the previous 25 years led to identification of several new species of microsporidia, many of which disseminate from enteric to systemic sites of infection and contribute to some unexpected lesions. Among non-HIV-infected but immune-suppressed individuals, microsporidia have infected organ transplant recipients, children, the elderly, and patients with malignant disease and diabetes. In otherwise healthy immune-competent HIV seronegative populations, self-limiting diarrhea occurred in travelers and as a result of a foodborne outbreak associated with contaminated cucumbers. Keratitis due to microsporidiosis has become problematic and a recent longitudinal evaluation demonstrated that non-HIV-infected individuals seropositive for microsporidia who had no clinical signs continued to intermittently shed organisms in feces and urine. SUMMARY: Greater awareness and implementation of better diagnostic methods are demonstrating that microsporidia contribute to a wide range of clinical syndromes in HIV-infected and non-HIV-infected people. As such, microsporidia should be considered in differential diagnoses if no other cause can be defined.

Indexed as

AIDS-Related Opportunistic InfectionsAntiprotozoal AgentsHumansImmunocompromised HostMicrosporidiosisAntiprotozoal Agents

Identifiers

PMID21844802
PMCPMC3416021
OpenAlexW1981980855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.